PIRS - Pieris Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Pieris Pharmaceuticals's activity chart (see below) currently has 7 price targets and 6 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 41.67% with an average time for these price targets to be met of 127.75 days.

Most recent stock forecast was given by ROGER SONG from JEFFERIES on 18-May-2021. First documented stock forecast 05-Aug-2016.

Best performing analysts who are covering PIRS - Pieris Pharmaceuticals:

Joseph Pantginis Madhu Kumar Roger Song

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 18-May-2021

$480

$467.97 (3890.02%)

5 years 5 months 16 days ago
(18-May-2021)

0/1 (0%)

$326.4 (212.50%)

Hold Since 13-Mar-2020

$400

$387.97 (3225.02%)

$400

6 years 7 months 21 days ago
(13-Mar-2020)

3/3 (100%)

$227.2 (131.48%)

209

Buy Since 05-Aug-2016

$720

$707.97 (5885.04%)

$400

6 years 9 months 7 days ago
(27-Jan-2020)

2/3 (66.67%)

$477.6 (197.03%)

302

Show more analysts

Please expand the browser size to see the chart

What is PIRS (Pieris Pharmaceuticals) average time for price targets to be met?

On average it took 128 days for the stock forecasts to be reached, with an average price target met ratio of 41.67%.

Which analyst most recently updated their price target on PIRS (Pieris Pharmaceuticals)?

Roger Song

Which analyst has the most public recommendations on PIRS (Pieris Pharmaceuticals)?

Roger Song works at JEFFERIES and has 4 price targets and 3 ratings on PIRS

Which analyst is the currently most bullish on PIRS (Pieris Pharmaceuticals)?

Joseph Pantginis with the highest potential upside of $707.97

Which analyst is the currently most reserved on PIRS (Pieris Pharmaceuticals)?

Madhu Kumar with the lowest potential downside of $387.97
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?